@MrSpecul8, if I was an active investor in the biotech sector I would be running a free trial of TrialKey with a view to subscribing.
I would be identifying each listed company - be it Australian or otherwise - that's running a clinical trial.
And I would be testing the TrialKey trial outcome forecast.
Given that OPL claims to have correctly forecast the success of Pfizer and Moderna vaccines for COVID19, I think it behoves any astute fund manager to give TrialKey a crack.
OPL Price at posting:
2.5¢ Sentiment: Hold Disclosure: Held
